يسرا: المتعايش مع فيروس الإيدز لا يستطيع العيش في مجتمعنا

Negotiating the UNGASS outcome document: Challenges and the way forward

MENAHRA website is updated on a regular basis. For more information and updates please visit www.menahra.org

يتم تحديث موقع "مينارة" الإلكتروني بشكل منتظم. للمزيد من المعلومات يرجى زيارة الموقع
www.menahra.org 

الإيدز: اتجاهات منذرة في العالم العربي

تمنع الوصمة الناس من معرفة حالة إصابتهم بفيروس العوز المناعي البشري. وتمنع المصابين من طلب علاج مبكر فعال لهذا الفيروس. فهي تعطّل المناقشة والمشاركة المجتمعية الأساسية للمعلومات التوعوية، وخاصة بين جيل الشباب. تتمة

War on Drugs Takes Center Stage at UN as Global Leaders and International Activists Assemble in NY

Huffington Post - In April, the world will come together to talk about drugs. The United Nations will host a General Assembly Special Session on Drugs (UNGASS), the most significant high-level international drug policy event in almost two decades. Read More

Thousands to get access to new HIV drug

The Age- Access to a drug lauded for halting the spread of HIV will be provided to more than 2500 people in a push to wipe out new infections. A major expansion of a trial for the Pre-exposure Prophylaxis (PReP) drug will begin later this year. Read More

New Report and Monitoring Tool: HIV, HCV, TB and Harm Reduction in Prisons

HRI - Even though prisoners do not forfeit their human rights, such as the right to health, there is an enormous gap between health and human rights standards and their effective implementation in places of detention. Read More

Drug policies in Africa: What is the 'health-based' approach?

IDPC - Fifty-five years since the Single Convention on Narcotic Drugs was adopted, creating the framework for the global drug control system, there is now mounting evidence that the “war on drugs” approach has led to serious negative consequences. Read More

HIV becoming resistant to key drug, study finds

BBC - Strains of HIV are becoming resistant to an antiretroviral drug commonly used to prevent and fight the virus, research has suggested. HIV was resistant to the drug Tenofovir in 60% of selected cases in some African countries. Read More